Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics

References

• Alonso-Sandel M, Cuña M, Remuñn-López C, Teijeiro-Osorio D, Alonso-Lebrero JL, Alonso MJ. (2006). Formation of New Glucomannan-Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins. Macromolecules, 39, 4152–4158. (Alonso-Sandel, 2006)
   Web of Science ®Google Scholar
• Babizhayev MA, Yegorov YE. (2010). Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic. Recent Pat Drug Deliv Formul, 4, 198–230. (Babizhayev, 2010)
   PubMedGoogle Scholar
• Bright GR, Kuo NT, Chow D, Burden S, Dowe C, Przybylski RJ. (1996). Delivery of macromolecules into adherent cells via electroporation for use in fluorescence spectroscopic imaging and metabolic studies. Cytometry, 24, 226–233. (Bright, 1996)
   PubMedGoogle Scholar
• Buse J, El-Aneed A. (2010). Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. Nanomedicine (Lond), 5, 1237–60. (Buse, 2010)
   PubMed Web of Science ®Google Scholar
• Cai SR, Xu G, Becker-Hapak M, Ma M, Dowdy SF, McLeod HL. (2006). The kinetics and tissue distribution of protein transduction in mice. Eur J Pharm Sci, 27, 4311–319. (Cai, 2006)
   Google Scholar
• Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, Bresolin N, Tremblay JP. (2001). Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther, 3, 3310–318. (Caron, 2001)
   Google Scholar
• Cassinelli G, Lanzi C, Petrangolini G, Tortoreto M, Pratesi G, Cuccuru G, Laccabue D, Supino R, Belluco S, Favini E, Poletti A, Zunino F. (2006). Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1. Mol Cancer Ther, 5, 2388–2397. (Cassinelli, 2006)
   PubMed Web of Science ®Google Scholar
• Chandna P, Saad M, Wang Y, Ber E, Khandarem J, Vetcher AA, Soldatenkov VA, Minko T. (2007). Targeted Proapoptotic Anticancer Drug Delivery System. Mol Pharm, 4, 668–678. (Chandna, 2007)
   PubMed Web of Science ®Google Scholar
• Chen YN, Sharma SK, Ramsey TM, Jiang L, Martin MS, Baker K, Adams PD, Bair KW, Kaelin WG Jr. (1999). Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci USA, 96, 4325–4329. (Chen, 1999)
   PubMed Web of Science ®Google Scholar
• Clark DD, Peterson BR. (2002). “Rapid Detection of Protein Tyrosine Kinase Activity in Recombinant Yeast Expressing a Universal Substrate” J. Proteome Res, 1, 207–209. (Clark, 2002)
   PubMed Web of Science ®Google Scholar
• Crombez L, Charnet A, Morris C, Aldrian-Herrada FG, Divita G. (2007). A non-covalent peptide-based strategy for siRNA delivery. Biochem Soc Trans, 35, 44–46. (Crombez, 2007)
   PubMed Web of Science ®Google Scholar
• Coulberson AL, Hud NV, LeDoux JM, Vilfan ID, Prausnitz MR. (2003). Gene packaging with lipids, peptides and viruses inhibits transfection by electroporation in vitro. J Control Release, 86, 361–370. (Coulberson, 2003)
   PubMed Web of Science ®Google Scholar
• Cronican JJ, Thompson DB, Beier KT, McNaughton BR, Cepko CL, Liu DR. (2010). Potent delivery of functional proteins into Mammalian cells in vitro and in vivo, using a supercharged protein. ACS Chem Biol, 5, 747–52. (Cronican, 2010)
   PubMed Web of Science ®Google Scholar
• Cuña M, Alonso-Sandel M, Remuñán-López C, Pivel JP, Alonso-Lebrero JL, Alonso MJ. (2006). Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol, 6, 2887–95. (Cuña, 2006)
   PubMed Web of Science ®Google Scholar
• Dalkara D, Chandrashekhar C, Zuber G. (2006). Intracellular protein delivery with a dimerizable amphiphile for improved complex stability and prolonged protein release in the cytoplasm of adherent cell lines. Journal of Controlled Release, 116, 353–359. (Dalkara, 2006)
   PubMed Web of Science ®Google Scholar
• Daniels DS, Schepartz A. (2007). Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif. J Am Chem Soc, 129,14578–14579. (Daniels, 2007)
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sánchez A, Alonso MJ. (2001). Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm, 224, 159–168. (De Campos, 2001)
   PubMed Web of Science ®Google Scholar
• Delom F, Fessart D, Caruso ME, Chevet E. (2007). Tat-mediated protein delivery in living Caenorhabditis elegans. Biochem Biophys Res Commun, 352, 587–591. (Delom, 2007)
   PubMed Web of Science ®Google Scholar
• Derossi D, Joliot AH, Chassaing G, Prochiantz A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 269, 10444–10450. (Derossi, 1994)
   PubMed Web of Science ®Google Scholar
• Deshayes S, Morris MC, Divita G, Heitz F. (2005). Interactions of primary amphipathic cell penetrating peptides with model membranes: consequences on the mechanisms of intracellular delivery of therapeutics. Curr Pharm Des, 11, 3629–3638. Review. (Deshayes, 2005)
   PubMed Web of Science ®Google Scholar
• Dietz GPH, Bahr M. (2004). Delivery of bioactive molecules into the cell: the Trojan horse approach. Molecular and Cellular Neuroscience, 27, 85–131. (Dietz, 2004)
   PubMed Web of Science ®Google Scholar
• Dudek AZ. (2010). Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapy. Translational Research, 156, 136–146. (Dudek, 2010)
   PubMed Web of Science ®Google Scholar
• Dudek NL, Perlmutter P, Aguilar MI, Croft NP, Purcell AW. (2010). Epitope discovery and their use in peptide based vaccines. Curr Pharm Des, 16(28),3149–57. (Dudek, 2010)
   PubMed Web of Science ®Google Scholar
• Eksioglu-Demiralp E, Kitada S, Carson D, Garland J, Andreef M, Reed JC. (2003). A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis. J Immunol Methods, 275, 41–56. (Eksioglu-Demiralp, 2003)
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Johansson HJ, Holm T, Langel U. (2007). Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. Mol Ther, 15, 1820–1826. (El-Andaloussi, 2007)
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Johansson HJ, Lundberg P, Langel U. (2006). Induction of splice correction by cell-penetrating peptide nucleic acids. J Gene Med, 8, 1262–1273. (El-Andaloussi, 2006)
   PubMed Web of Science ®Google Scholar
• El-Andaloussi SE, Guterstam P, Langel U. (2007). Assessing the delivery efficacy and internalization route of cell-penetrating peptides. Nat Protoc, 2, 2043–2047. (El-Andaloussi, 2007)
   PubMed Web of Science ®Google Scholar
• Elliott G, O’Hare P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein.Cell, 88, 223–233. (Elliott, 1997)
   PubMed Web of Science ®Google Scholar
• Fenton M, Bone N, Sinclair AJ. (1998). The efficient and rapid import of a peptide into primary B and T lymphocytes and a lymphoblastoid cell line. J Immunol Methods, 212, 41–48. (Fenton, 1998)
   PubMed Web of Science ®Google Scholar
• Frankel AD, Pabo CO. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 55, 1189–1193. (Frankel, 1988)
   PubMed Web of Science ®Google Scholar
• Fuchs SM, Raines RT. (2007). Arginine grafting to endow cell permeability. ACS Chem Biol, 2, 167–170. (Fuchs, 2007)
   PubMed Web of Science ®Google Scholar
• Fuchs SM, Rutkoski TJ, Kung VM, Groeschl RT, Raines RT. (2007). Increasing the potency of a cytotoxin with an arginine graft. Protein Eng Des Sel, 20, 505–509. (Fuchs, 2007)
   PubMed Web of Science ®Google Scholar
• Futami J, Kitazoe M, Maeda T, Nukui E, Sakaguchi M, Kosaka J, Miyazaki M, Kosaka M, Tada H, Seno M, Sasaki J, Huh N-H, Namba M, Yamada H. (2005). Intracellular delivery of proteins into mammalian living cells by polyethylenimine-cationization. Journal of Bioscience and Bioengineering, 99, 95–103. (Futami, 2005)
   PubMed Web of Science ®Google Scholar
• Gabel CA, Foster SA, (1986). Mannose 6-phosphate receptor-mediated endocytosis of acid hydrolases: internalization of beta-glucuronidase is accompanied by a limited dephosphorylation. J Cell Biol, 103, 51817–1827. (Gabel, 2006)
   Google Scholar
• Galan JE, Collmer A. (1999). Type III secretion machines: bacterial devices for protein delivery into host cells. Science, 284, 5418, 1322–1328. (Galan, 1999)
   Google Scholar
• Galan JE, Wolf-Watz H. (2006). Protein delivery into eukaryotic cells by type III secretion machines. Nature, 444, 567–573. (Galan, 2006)
   PubMed Web of Science ®Google Scholar
• Graessmann M, Graessmann A. (1983). Microinjection of tissue culture cells. Meth Enzymol, 101, 482–492. (Graessmann, 1983)
   PubMed Web of Science ®Google Scholar
• Green M, Loewenstein PM. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 55, 1179–1188. (Green, 1988)
   PubMed Web of Science ®Google Scholar
• Gupta Y, Ganesh N, Kohli DV, Jain SK. (2011). Development and Characterization of Doxorubicin Bearing Vitamin B12 Coupled Sterically Stabilized Liposomes for Tumor Targeting. Current Nanoscience, 7, 427–435. (Gupta, 2011)
   Web of Science ®Google Scholar
• Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM. (2009) Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem, 284, 6972–6981. (Hasadsri, 2009)
   PubMed Web of Science ®Google Scholar
• Heitz F, Morris MC, Divita G. (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol, 157, 2195–206. (Heitz, 2009)
   Google Scholar
• Howard WA Jr, Bayomi A, Natarajan E, Aziza MA, el-Ahmady O, Grissom CB, West FG. (1997). Sonolysis promotes indirect Co-C bond cleavage of alkylcob(III)alamin bioconjugates. Bioconjug Chem. 8(4), 498–502. (Howard, 1997).
   PubMed Web of Science ®Google Scholar
• Hussey SL, Peterson BR. (2002) Efficient Delivery of Streptavidin to Mammalian Cells: Clathrin-Mediated Endocytosis Regulated by a Synthetic Ligand. J Am Chem Soc, 124, 6265–6273. (Hussey, 2002)
   PubMed Web of Science ®Google Scholar
• Jain KK. (2010). Advances in the field of nanooncology. BMC Med, 8, 83. (Jain, 2010)
   PubMed Web of Science ®Google Scholar
• Järver P, Langel K, El-Andaloussi S, Langel U. (2007). Applications of cell-penetrating peptides in regulation of gene expression. Biochem Soc Trans, 35, 770–774. (Järver, 2007)
   PubMed Web of Science ®Google Scholar
• Johnson RM, Harrison SD, Maclean D. (2011). Therapeutic applications of cell-penetrating peptides. Methods Mol Biol, 683, 535–51. (Johnson, 2011)
   PubMedGoogle Scholar
• Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. (1991). Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A, 88, 1864–1868. (Joliot, 1991)
   PubMed Web of Science ®Google Scholar
• Kaczmarczyk SJ, Chatterjee DK. (2008). Novel Protein Delivery System for Mammalian Cells. Patent, HHS, Reference No. E-010–2008/0PCT. (Kaczmarczyk, 2008)
   Google Scholar
• Kaneda Y. (2010). Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. Expert Opin Drug Deliv, 7, 1079–93. (Kaneda, 2010)
   PubMed Web of Science ®Google Scholar
• Kilk K, El-Andaloussi S, Järver P, Meikas A, Valkna A, Bartfai T, Kogerman P, Metsis M, Langel U. (2005). Evaluation of transportan 10 in PEI mediated plasmid delivery assay. J Control Release, 10, 511–523. (Kilk, 2005)
   Google Scholar
• Koren E, Apte A, Sawant RR, Grunwald J, Torchilin VP. (2011). Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements. Drug Delivery, 2011. (doi:10.3109 /10717544.2011.567310) (Koren, 2011)
   Google Scholar
• Langel U. (2007). Handbook of cell-penetrating peptides, 2nd ed., U., Langel (Ed.), Boca Raton, London, New York: CRC Press, Taylor&Francis Group. (Langel, 2007)
   Google Scholar
• Lawrence MS, Phillips KJ, Liu DR. (2007). Supercharging proteins can impart unusual resilience. J Am Chem Soc, 129, 10110–10112.. (Lawrence, 2007)
   Google Scholar
• Leamon CP, Low PS. (1991). Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA 88, 5572–5576. (Leamon, 1991)
   PubMed Web of Science ®Google Scholar
• Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu L, Westrick E. (2005). Synthesis and Biological Evaluation of EC72: A New Folate-Targeted Chemotherapeutic. Bioconjugate Chem. 16, 803–811. (Leamon, 2005)
   PubMed Web of Science ®Google Scholar
• Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323–331. (Levine, 1997)
   PubMed Web of Science ®Google Scholar
• Liao F, Shin HS, Rhee SG. (1993). In vitro tyrosine phosphorylation of PLC-gamma 1 and PLC-gamma 2 by src-family protein tyrosine kinases. Biochem Biophys Res Commun, 3, 1028–33. (Liao, 1993)
   Google Scholar
• Lin YZ, Yao SY, Hawiger J. (1996). Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways of special interest. J Biol Chem, 271, 5305–5308. (Lin, 1996)
   PubMed Web of Science ®Google Scholar
• Low PS, Henne WA, Doorneweerd DD. XXXX Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases. Acc Chem Res, 41(1), 120–129. (Low, 2008)
   PubMed Web of Science ®Google Scholar
• Lukas J, Bartek J, Strauss M. (1994). Efficient transfer of antibodies into mammalian cells by electroporation. J Immunol Methods, 17, 255–9. (Lukas, 1994)
   Google Scholar
• Marrero MB, Schieffer B, Paxton WG, Schieffer E, Bernstein KE. (1995). Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells. J Biol Chem, 270, 15734–8. (Marrero, 1995)
   PubMed Web of Science ®Google Scholar
• Mashiba H, Ozaki Y, Ikuno S, Matsunaga K. (2001). Augmentation of antiproliferative and antitumor effect on human cancer cells in combined use of electroporation with a plant toxin, saporin. Cancer Biother Radiopharm, 16, 495–9. (Mashiba, 2001)
   PubMed Web of Science ®Google Scholar
• May CM, Depollier J, Mery J, Heitz F, Divita G. (2001). A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nature Biotechnology 19, 1173–1176. (Morris, 2001)
   PubMed Web of Science ®Google Scholar
• McNaughton BR, Cronican JJ, Thompson DB, Liu DR. (2009). Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Pro. Natl Acad Sci USA, 106, 156111–6116. (McNaughton, 2009)
   Google Scholar
• Nagaraj NS, Singh OV, Merchant NB. (2010). Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy. Expert Rev Proteomics, 7, 613–23. (Nagaraj, 2010)
   PubMed Web of Science ®Google Scholar
• Nakanishi O, Shibasaki F, Hidaka M, Homma Y, Takenawa T. (1993). Phospholipase C-gamma 1 associates with viral and cellular src kinases. J Biol Chem, 268, 10754–10759. (Nakanishi, 1993)
   PubMed Web of Science ®Google Scholar
• Okada CY, Rechsteiner M. XXXX Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell, 29, 33–41. (Okada, 1982)
   PubMed Web of Science ®Google Scholar
• Patsch C, Kesseler D, Edenhofer F. (2010). Genetic engineering of mammalian cells by direct delivery of FLP recombinase protein. Methods, 53, 386–393. (Patsch, 2010)
   PubMed Web of Science ®Google Scholar
• Phelan A, Elliott G, O’Hare P. (1998). Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol, 16, 440–443. (Phelan, 1998)
   PubMed Web of Science ®Google Scholar
• Pitt WG, Husseini GA, Staples BJ. (2004). Ultrasonic drug delivery-a general review. Expert Opin Drug Deliv, 1(1), 37–56. (Pitt, 2004).
   PubMedGoogle Scholar
• Potts RO, Bommannan D, Wong O, Tamada A, Riviere E, Monteiro-Riviere A. (1997). Transdermal peptide delivery using electroporation. Pharm Biotechnol, 10, 213–238. (Potts, 1997)
   PubMedGoogle Scholar
• Price VH. (2003). Therapy of alopecia areata: on the cusp and in the future. Journal Invest Dermatol Symp Proc, 8, 207–211. (Price, 2003)
   PubMed Web of Science ®Google Scholar
• Raptis LH, Brownell HL, Liu SK, Firth KL, MacKenzie LW, Stiles SD, Alberta JA. (1995). Applications of electroporation of adherent cells in situ, on a partly conductive slide. Mol Biotechnol, 4, 129–138. (Raptis, 1995)
   PubMed Web of Science ®Google Scholar
• Raptis LH, Liu SK, Firth KL, Stiles SD, Alberta JA. (1995). Electroporation of peptides into adherent cells in situ. Biotechniques, 18, 104–110. (Raptis, 1995)
   PubMed Web of Science ®Google Scholar
• Reddy JA, Westrick E, Vlahov I, Howard SJ, Santhapuram HK, Leamon CP. (2006). Folate Receptor Specific Anti-Tumor Activity of Folate-Mitomycin Conjugates. Cancer Chemother. Pharmacol, 58, 229–236. (Reddy, 2006)
   Web of Science ®Google Scholar
• Rizk SS, Luchniak A, Uysal S, Brawley CM, Rock RS, Kossiakoff AA. (2009). An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc Nat Acad Sci USA, 106, 11011–11015. (Rizk, 2009)
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Sahlgren C, Lindén M. (2010) Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles–opportunities & challenges. Nanoscale, 2, 1870–83. (Rosenholm, 2010)
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Jessop TC, Wender PA. (2005). Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev, 57, 495–504. (Rothbard, 2005)
   PubMed Web of Science ®Google Scholar
• Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M. (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov, 9, 971–88. (Rupprecht, 2010)
   PubMed Web of Science ®Google Scholar
• Russell-Jones G, McTavish K, McEwan J, Rice J, Nowotnik D. (2004). Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. J Inorg Biochem, 98(10), 1625–33. (Russell-Jones, 2004)
   PubMed Web of Science ®Google Scholar
• Säälik P, Elmquist A, Hansen M, Padari K, Saar K, Viht K, Langel U, Pooga M. (2004). Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem, 15, 1246–53. (Säälik, 2004)
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. (1999). In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse. Science, 285, 1569–1572. (Schwarze, 1999)
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Hruska KA, Dowdy SF. (2010). Protein transduction: unrestricted delivery into all cells? Trends Cell Biol, 10, 290–295. (Schwarze, 2000)
   Google Scholar
• Sebbage V. (2009). Review. Cell-penetrating peptides and their therapeutic applications. Bioscience Horizons, 2, 64–72. (Sebbage, 2010)
   Google Scholar
• Smith BA, Daniels DS, Coplin AE, Jordan GE, McGregor LM, Schepartz A. (2008). Minimally cationic cell-permeable miniature proteins via α-helical arginine display. J Am Chem Soc, 130, 2948–2949. (Smith, 2008)
   PubMed Web of Science ®Google Scholar
• Stewart KM, Horton KL, Kelley SO. (2008). Cell-penetrating peptides as delivery vehicles for biology and medicine. Org Biomol Chem, 6, 2242–2255. (Stewart, 2008)
   PubMed Web of Science ®Google Scholar
• Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. (2002). Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277, 2437–2443. (Suzuki, 2002)
   Google Scholar
• Thoren PE, Persson D, Karlsson M, Norden B. (2000). The antennapedia peptide penetratin translocates across lipid bilayers: The first direct observation. FEBS Lett, 482, 265–268. (Thoren, 2000)
   PubMed Web of Science ®Google Scholar
• Todorova R. (2009). Estimation of methods of protein delivery into mammalian cells–a comparative study by electroporation and bioporter assay. Appl Biochem Microbil, 45(4), 493–6. (Todorova, 2009)
   Google Scholar
• Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. (2010). Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small, 6, 1952–67. (Vivero-Escoto, 2010)
   PubMed Web of Science ®Google Scholar
• Vocero-Akbani AM, Heyden NV, Lissy NA, Ratner L, Dowdy SF. (1999). Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med, 5, 29–33. (Vocero-Akbani, 1999)
   PubMed Web of Science ®Google Scholar
• Wadia JS, Dowdy SF. (2003) Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci, 4, 297–304. (Wadia, 2003)
   Google Scholar
• Wadia JS, Dowdy SF. (2005). Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev, 57, 579–596. (Wadia, 2005)
   PubMed Web of Science ®Google Scholar
• Watanabe S, Wakasugi K. (2008). Neuroprotective function of human neuroglobin is correlated with its guanine nucleotide dissociation inhibitor activity. Biochem Biophys Res Commun, 369, 695–700. (Watanabe, 2008)
   PubMed Web of Science ®Google Scholar
• Waibel R, Treichler H, Schaefer NG, van Staveren DR, Mundwiler S, Kunze S, Küenzi M, Alberto R, Nüesch J, Knuth A, Moch H,Schibli R, Schubiger PA. (2008). New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Res, 68(8), 2904–11. (Waibel, 2008)
   PubMed Web of Science ®Google Scholar
• Wang S, Low PS. (1998). Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. Journal Controlled Release, 53, 39–48. (Wang, 1998)
   PubMed Web of Science ®Google Scholar
• Ye F, Fang L, Picard LAG, Webb BL (2005). Method and device for protein delivery into cells. United States Patent 7829290. (Ye, 2005)
   Google Scholar
• Zelphati O, Wang Y, Kitada S, Reed JC, Felgner PL, Corbeil J. (2001). Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem, 276, 35103–35110. (Zelphati, 2001)
   PubMed Web of Science ®Google Scholar
• Zheng X, Lundberg M, Karlsson A, Johansson M. (2003). Lipid-mediated protein delivery of suicide nucleoside kinases. Cancer Res, 63, 6909–6913. (Zheng, 2003)
   PubMed Web of Science ®Google Scholar